研究者業績

西澤 春紀

ニシザワ ハルキ  (nishizawa haruki)

基本情報

所属
藤田医科大学 医学部 産婦人科学 教授
(兼任)臨床研修センター副センター長
学位
博士(医学)

J-GLOBAL ID
201501014781972565
researchmap会員ID
7000012955

日本産科婦人科学会 専門医・指導医

日本周産期・新生児医学会 周産期(母体・胎児)専門医・指導医

日本人類遺伝学会・日本遺伝カウンセリング学会 臨床遺伝専門医

日本生殖医学会 生殖医療専門医

日本産科婦人科内視鏡学会 技術認定医

日本内視鏡外科学会 技術認定医

日本婦人科ロボット手術学会 婦人科ロボット支援手術プロクター

日本ロボット外科学会専門医(国内A級)


論文

 142
  • Yuri Murase, Yui Shichiri, Hidehito Inagaki, Tatsuya Nakano, Yoshiharu Nakaoka, Yoshiharu Morimoto, Tomoko Ichikawa, Haruki Nishizawa, Eiji Sugihara, Hiroki Kurahashi
    Genes 15(8) 2024年8月21日  
    Cytogenetic information about the product of conception (POC) is important to determine the presence of recurrent chromosomal abnormalities that are an indication for preimplantation genetic testing for aneuploidy or structural rearrangements. Although microscopic examination by G-staining has long been used for such an evaluation, detection failures are relatively common with this method, due to cell-culture-related issues. The utility of low-coverage whole-genome sequencing (lcWGS) using short-read next-generation sequencing (NGS) has been highlighted recently as an alternative cytogenomic approach for POC analysis. We, here, performed comparative analysis of two NGS-based protocols for this purpose based on different short-read sequencers (the Illumina VeriSeq system using a MiSeq sequencer and the Thermo Fisher ReproSeq system using an Ion S5 sequencer). The cytogenomic diagnosis obtained with each NGS method was equivalent in each of 20 POC samples analyzed. Notably, X chromosome sequence reads were reduced in some female samples with both systems. The possibility of low-level mosaicism for monosomy X as an explanation for this was excluded by FISH analysis. Additional data from samples with various degrees of X chromosome aneuploidy suggested that it was a technical artifact related to X chromosome inactivation. Indeed, subsequent nanopore sequencing indicated that the DNA in the samples showing the artifact was predominantly unmethylated. Our current findings indicate that although X chromosome data must be interpreted with caution, both the systems we tested for NGS-based lcWGS are useful alternatives for the karyotyping of POC samples.
  • Hironori Miyamura, Kyohei Takada, Akiko Ohwaki, Arata Kobayashi, Mayuko Ito, Hiroyuki Nomura, Eiji Nishio, Haruki Nishizawa
    Asian journal of endoscopic surgery 17(2) e13298 2024年4月  
    INTRODUCTION: The da Vinci SP surgical system is a surgical platform capable of implementing robotic-assisted surgery through a single port and was first introduced in Japan at our hospital. In this paper, we describe our experience of the initial introduction of the da Vinci SP surgical system and its surgical outcomes. This is the first report on the surgical outcomes of using da Vinci SP, and its comparison with the conventional system in Japan. METHODS: After developing an application for a highly difficult new medical technology in-house, we compared the surgical outcomes (median values) of 15 patients who had undergone total hysterectomy at our hospital using the da Vinci SP (1-port) system (SP group) for uterine myoma after March 2023 and of 154 patients who underwent total hysterectomy using the conventional da Vinci Xi (four ports) system (Xi group) for uteri weighing <500 g. RESULTS: The results of the comparison of the characteristics between 15 patients in the SP group and 154 patients in the Xi group were as follows: uterus weight (g): 230 (90-500) versus 222 (55-496) (p = .35); surgical time (minutes): 199 (171-251) versus 198 (88-387) (p = .63); intraoperative blood loss (mL): 13 (5-82) versus 20 (2-384) (p = .17); and rate of surgical complication (%): 0.0 versus 1.3 (p = .66). The data indicated a comparable weight of the resected uterus, surgical time, intraoperative blood loss, and rate of surgical complications between the two groups. CONCLUSION: Robotic-assisted total hysterectomy using the da Vinci SP surgical system allowed clinicians to safely perform surgeries according to the conventional systems.
  • 高田 恭平, 西尾 永司, 高木 淳一, 小谷 燦璃古, 関谷 隆夫, 西澤 春紀
    東海産科婦人科学会雑誌 60 366-366 2024年3月  
  • 内藤 佳奈, 森山 佳則, 中島 葉月, 三谷 武司, 坂部 慶子, 野田 佳照, 仲村 将光, 関谷 隆夫, 西澤 春紀
    日本産科婦人科学会雑誌 76(臨増) S-557 2024年2月  
  • Eiji Nishio, Aya Iwata, Rie Kawasaki, Kukimoto Iwao, Haruki Nishizawa, Takuma Fujii
    Reproductive Medicine and Biology 23(1) 2024年1月  
    Abstract Purpose In the context of in vitro fertilization–embryo transfer (IVF–ET), factors other than egg quality may be key determinants of treatment success, in particular, maternal factors related to uterine endometrial receptivity and unidentified factors. We therefore aimed to analyze the metabolome and microbiome in IVF–ET patients who did and did not achieve pregnancy. Methods Cervicovaginal mucus was collected from patients undergoing IVF–ET. Metabolite analysis was conducted by liquid chromatography‐mass spectrometry and the microbiota were determined by the polymerase chain reaction using universal 16S‐rRNA gene bacterial primers by MiSeq sequencing. Patients were classified as pregnant (N = 10) or nonpregnant (N = 13). Metabolic pathways were examined by MetaboAnalyst. Results Three metabolic pathways, including alanine‐aspartate–glutamate metabolism, arginine biosynthesis, and cysteine‐methionine metabolism, were commonly decreased at the time of embryo transfer irrespective pregnant outcomes. Notably, pyruvate was decreased in the pregnant group. Amino acid metabolites showed inverse correlations with the presence of anaerobic microbiota in the nonpregnant group. Conclusions Metabolism decreased during embryo transplantation, with a notable decrease in pyruvate metabolism, particularly in patients who became pregnant. The behavior of metabolites in the pregnant and nonpregnant groups suggests that metabolome analysis in the cervicovaginal mucus may be a diagnostic marker for predicting pregnancy.

MISC

 85

書籍等出版物

 2
  • 廣田 穰,西澤春紀,西尾永司,安江 朗 (担当:共著, 範囲:OGS NOW No.21 婦人科ロボット支援手術(平松祐司,小西郁生,櫻木範明,竹田省編))
    メディカルビュー社 2015年
  • Nishizawa H, Kurahashi H (担当:共著, 範囲:Clinical Genomics: Practical Applications in Adult Patient Care)
    The McGraw-Hill Education 2014年

講演・口頭発表等

 29

共同研究・競争的資金等の研究課題

 2

その他

 1
  • 母体cfDNAを利用した胎児成分の検出方法(日本特許出願済)) 本研究シーズに関する産学共同研究の問い合わせは藤田医科大学産学連携推進センター(fuji-san@fujita-hu.ac.jp)まで。